A recent study has revealed significant disparities in prostate cancer diagnosis and outcomes for men with learning disabilities, adding to growing evidence about inequalities in cancer care pathways. The research, led by teams at the University of Manchester and The Christie NHS Foundation Trust, found that men with learning disabilities were substantially less likely to receive key diagnostic tests such as PSA (prostate-specific antigen) screening, timely referrals and biopsies - and were more likely to be diagnosed at an advanced stage or at the time of death.
This work builds on earlier insights generated through the SPCR-funded Project 514, Presenting Complaints for Prostate Cancer in Primary Care: The PC3 study led by Dr Sam Merriel and Professor Darren Ashcroft. That study explored how symptoms are presented in primary care and helped improve understanding of which clinical presentations should prompt urgent investigation for prostate cancer.
By combining large-scale hospital, cancer registry and primary care data, the latest study highlights how men with learning disabilities are more likely to experience prostate cancer symptoms but far less likely to complete the diagnostic pathway, contributing to poorer survival. Addressing these inequalities will require targeted action across primary and secondary care.
For more on the Manchester research and the inequalities it outlines, read the full article Study reveals inequalities in men with learning disabilities and prostate cancer.